Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States
<p>Abstract</p> <p>Background</p> <p>Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are frequent and life-threatening complications of ischemic stroke. We evaluated rates of symptomatic DVT/PE, and of in-hospital and post-discharge thromboprophylaxis in patients...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-02-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2377/13/17 |
id |
doaj-5467c2cf98ab4c769d0ed31d6b46533b |
---|---|
record_format |
Article |
spelling |
doaj-5467c2cf98ab4c769d0ed31d6b46533b2020-11-25T01:04:43ZengBMCBMC Neurology1471-23772013-02-011311710.1186/1471-2377-13-17Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United StatesAmin Alpesh NLin JayThompson StephenWiederkehr Daniel<p>Abstract</p> <p>Background</p> <p>Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are frequent and life-threatening complications of ischemic stroke. We evaluated rates of symptomatic DVT/PE, and of in-hospital and post-discharge thromboprophylaxis in patients with acute ischemic stroke (AIS).</p> <p>Methods</p> <p>In a retrospective US database analysis, data were extracted from the Premier Perspective™-i3 Pharma Informatics linked database for patients aged ≥18 years who were hospitalized for ischemic stroke from January 2005 to November 2007, and who had ≥6 months’ continuous plan enrollment prior to index hospitalization. Patients discharged to an acute-care facility or with atrial fibrillation were excluded. Prophylaxis was evaluated during index hospitalization and for 14 days’ post-discharge. DVT/PE rates were calculated during index hospitalization and up to 30 days post-discharge.</p> <p>Results</p> <p>A total of 1524 patients were included; 46.1% received pharmacological and/or mechanical prophylaxis in-hospital (28.3%, 11.4% and 12.3% received unfractionated heparin, enoxaparin and mechanical prophylaxis, respectively). 6.4% of patients received outpatient pharmacological prophylaxis; warfarin was most frequently prescribed (5.9%). Total mean ± standard deviation length of index hospitalization was 3.0 ± 2.5 days. Mean prophylaxis duration in all patients was 0.9 ± 1.5 days in-hospital and 1.7 ± 6.9 days post-discharge. Symptomatic DVT/PE occurred in 25 patients overall (1.64%), with an inpatient rate of 0.98% and an outpatient rate of 0.66%.</p> <p>Conclusions</p> <p>Approximately 1% of patients with AIS experienced symptomatic in-hospital and/or post-discharge DVT/PE. Although 46% received prophylaxis in-hospital, only 6% received prophylaxis in the outpatient setting. This highlights the need for sustained thromboprophylaxis prescribing across the continuum of care.</p> http://www.biomedcentral.com/1471-2377/13/17Acute ischemic strokeCare continuumDeep-vein thrombosisPulmonary embolismThromboprophylaxis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amin Alpesh N Lin Jay Thompson Stephen Wiederkehr Daniel |
spellingShingle |
Amin Alpesh N Lin Jay Thompson Stephen Wiederkehr Daniel Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States BMC Neurology Acute ischemic stroke Care continuum Deep-vein thrombosis Pulmonary embolism Thromboprophylaxis |
author_facet |
Amin Alpesh N Lin Jay Thompson Stephen Wiederkehr Daniel |
author_sort |
Amin Alpesh N |
title |
Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States |
title_short |
Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States |
title_full |
Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States |
title_fullStr |
Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States |
title_full_unstemmed |
Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States |
title_sort |
rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the united states |
publisher |
BMC |
series |
BMC Neurology |
issn |
1471-2377 |
publishDate |
2013-02-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Deep-vein thrombosis (DVT) and pulmonary embolism (PE) are frequent and life-threatening complications of ischemic stroke. We evaluated rates of symptomatic DVT/PE, and of in-hospital and post-discharge thromboprophylaxis in patients with acute ischemic stroke (AIS).</p> <p>Methods</p> <p>In a retrospective US database analysis, data were extracted from the Premier Perspective™-i3 Pharma Informatics linked database for patients aged ≥18 years who were hospitalized for ischemic stroke from January 2005 to November 2007, and who had ≥6 months’ continuous plan enrollment prior to index hospitalization. Patients discharged to an acute-care facility or with atrial fibrillation were excluded. Prophylaxis was evaluated during index hospitalization and for 14 days’ post-discharge. DVT/PE rates were calculated during index hospitalization and up to 30 days post-discharge.</p> <p>Results</p> <p>A total of 1524 patients were included; 46.1% received pharmacological and/or mechanical prophylaxis in-hospital (28.3%, 11.4% and 12.3% received unfractionated heparin, enoxaparin and mechanical prophylaxis, respectively). 6.4% of patients received outpatient pharmacological prophylaxis; warfarin was most frequently prescribed (5.9%). Total mean ± standard deviation length of index hospitalization was 3.0 ± 2.5 days. Mean prophylaxis duration in all patients was 0.9 ± 1.5 days in-hospital and 1.7 ± 6.9 days post-discharge. Symptomatic DVT/PE occurred in 25 patients overall (1.64%), with an inpatient rate of 0.98% and an outpatient rate of 0.66%.</p> <p>Conclusions</p> <p>Approximately 1% of patients with AIS experienced symptomatic in-hospital and/or post-discharge DVT/PE. Although 46% received prophylaxis in-hospital, only 6% received prophylaxis in the outpatient setting. This highlights the need for sustained thromboprophylaxis prescribing across the continuum of care.</p> |
topic |
Acute ischemic stroke Care continuum Deep-vein thrombosis Pulmonary embolism Thromboprophylaxis |
url |
http://www.biomedcentral.com/1471-2377/13/17 |
work_keys_str_mv |
AT aminalpeshn rateofdeepveinthrombosisandpulmonaryembolismduringthecarecontinuuminpatientswithacuteischemicstrokeintheunitedstates AT linjay rateofdeepveinthrombosisandpulmonaryembolismduringthecarecontinuuminpatientswithacuteischemicstrokeintheunitedstates AT thompsonstephen rateofdeepveinthrombosisandpulmonaryembolismduringthecarecontinuuminpatientswithacuteischemicstrokeintheunitedstates AT wiederkehrdaniel rateofdeepveinthrombosisandpulmonaryembolismduringthecarecontinuuminpatientswithacuteischemicstrokeintheunitedstates |
_version_ |
1725196456026963968 |